Equities

Neuroone Medical Technologies Corp

NMTC:NAQ

Neuroone Medical Technologies Corp

Actions
FinancialsInvestment Banking and Brokerage Services
  • Price (USD)1.15
  • Today's Change0.028 / 2.52%
  • Shares traded80.43k
  • 1 Year change-13.67%
  • Beta1.0193
Data delayed at least 15 minutes, as of May 09 2024 19:41 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. The Company is focused on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure and artificial intelligence. Its Evo cortical electrode technology records, monitors, and stimulates brain tissue on the surface of the brain. Its products include strip/grid, depth electrodes (sEEG Products) and electrode cable assembly products.

  • Revenue in USD (TTM)2.86m
  • Net income in USD-13.47m
  • Incorporated2017
  • Employees16.00
  • Location
    Neuroone Medical Technologies Corp7599 Anagram DrEDEN PRAIRIE 55344-7399United StatesUSA
  • Phone+1 (952) 426-1383
  • Fax+1 (302) 655-5049
  • Websitehttps://nmtc1.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Neuraxis Inc2.46m-14.63m20.77m17.00------8.44-3.78-3.780.5432------------------87.67---594.57-----23.75-----8.37---163.78------
Ekso Bionics Holdings Inc17.91m-14.24m25.08m70.00--1.78--1.40-0.9685-0.96851.200.77650.54231.653.38255,900.00-43.11-43.63-57.86-57.6750.4151.93-79.48-104.242.11-34.630.2937--41.5710.03-0.7825--3.69--
SANUWAVE Health Inc20.40m-25.81m25.09m31.00------1.23-0.0455-0.04550.0257-0.03790.96473.165.56657,967.80-122.05-136.54----70.4169.13-126.52-189.600.1055-0.0214----21.8461.61-150.72------
Positron Corp1.24m-1.27m28.67m22.00------23.18-0.0897-0.08970.0876-0.11090.59762.296.56---61.35-224.13----32.989.85-102.67-201.870.0638-------10.060.275163.63--4.36--
Neuroone Medical Technologies Corp2.86m-13.47m29.04m16.00--6.29--10.17-0.6922-0.69220.14240.17790.3691.668.94178,516.30-174.02-172.88-211.08-274.7427.16---471.65-674.972.52--0.00--62.66---18.60------
BioRegenx Inc22.24k-571.17k29.66m10.00------1,333.43-0.0021-0.00210.00008-0.00080.4899----2,224.00-1,258.22------96.85---2,568.21-----13.2366.29---47.25---629.37------
Femasys Inc1.07m-14.25m30.89m32.00--1.64--28.81-0.9396-0.93960.06970.84740.0480.688612.1633,498.75-63.81---71.11--64.54---1,329.07--7.37--0.2675---11.13---25.04------
Akili Inc1.68m-59.49m31.91m68.00--0.5435--19.02-0.761-0.7610.02150.7470.0149--9.8424,676.47-52.90---59.98--51.19---3,545.47-----27.180.1817--419.50---212.48------
Harvard Apparatus Regenertv Tchnlgy Inc103.00k-9.02m32.21m10.00--19.07--312.71-0.6801-0.68010.00770.1180.0411----10,300.00-356.80-330.30-666.79-1,524.8876.70---8,684.47-35,138.840.7572--0.00-------44.28---39.07--
Retractable Technologies Inc43.60m-7.24m32.48m148.00--0.3279114.280.745-0.242-0.2421.463.320.23231.805.62294,573.80-3.7412.45-3.9614.5120.8940.82-16.0818.096.41-3.150.0153---54.025.55-249.46--17.42--
SeaStar Medical Holding Corp0.00-26.23m32.70m12.00---------1.28-1.280.00-0.29130.00----0.00-800.85-----------------26.51---------115.19------
Precision Optics Corporation Inc19.22m-1.72m34.69m84.00--3.06--1.80-0.289-0.2893.271.871.094.315.09228,782.90-9.77-6.71-13.54-10.5533.3533.65-8.94-5.021.10-10.390.1823--34.2339.1284.42--19.39--
Inspira Technologies Oxy BHN Ltd0.00-11.29m36.14m37.00--5.70-----0.9549-0.95490.000.36660.00----0.00-88.60-114.98-108.36-159.56------------0.00------24.64------
Nutriband Inc2.09m-5.49m36.97m13.00--4.64--17.73-0.6863-0.68630.26220.72670.24576.1515.94---64.63-55.21-72.05-66.7441.3433.32-263.05-315.870.854-82.630.0312--0.274153.43-22.35--65.57--
Data as of May 09 2024. Currency figures normalised to Neuroone Medical Technologies Corp's reporting currency: US Dollar USD

Institutional shareholders

24.85%Per cent of shares held by top holders
HolderShares% Held
Manchester Management Co. LLCas of 25 Jan 20242.36m9.12%
AWM Investment Co., Inc.as of 31 Dec 20231.45m5.59%
Nantahala Capital Management LLCas of 31 Dec 20231.21m4.68%
The Vanguard Group, Inc.as of 31 Dec 2023917.63k3.54%
Geode Capital Management LLCas of 31 Dec 2023197.12k0.76%
Perkins Capital Management, Inc.as of 31 Dec 2023150.00k0.58%
SSgA Funds Management, Inc.as of 31 Dec 202351.60k0.20%
MAI Capital Management LLCas of 31 Dec 202350.00k0.19%
Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 202330.28k0.12%
Virtu Americas LLCas of 31 Dec 202318.12k0.07%
More ▼
Data from 31 Dec 2023 - 16 Feb 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.